Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Article Title: Development of Pyridazinone Chemotypes Targeting the PDE? Prenyl Binding Site.

PMID/MRN: 27809361

Publication Date: 2016-Nov-03

Abstract:

The K-Ras GTPase is a major target in anticancer drug discovery. However, direct interference with signaling by K-Ras has not led to clinically useful drugs yet. Correct localization and signaling by farnesylated K-Ras is regulated by the prenyl binding protein PDE?. Interfering with binding of PDE? to K-Ras by means of small molecules provides a novel opportunity to suppress oncogenic signaling. Here we describe the identification and structure-guided development of novel K-Ras-PDE? inhibitor chemotypes based on pyrrolopyridazinones and pyrazolopyridazinones that bind to the farnesyl binding pocket of PDE? with low nanomolar affinity. We delineate the structure-property relationship and in vivo pharmacokinetic (PK) and toxicokinetic (Tox) studies for pyrazolopyridazinone-based K-Ras-PDE? inhibitors. These findings may inspire novel drug discovery efforts aimed at the development of drugs targeting oncogenic Ras. © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.